List of Tables
Table 1. Spine Osteoarthritis Pain Drug Market Trends
Table 2. Spine Osteoarthritis Pain Drug Market Drivers & Opportunity
Table 3. Spine Osteoarthritis Pain Drug Market Challenges
Table 4. Spine Osteoarthritis Pain Drug Market Restraints
Table 5. Global Spine Osteoarthritis Pain Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Company (2019-2024)
Table 7. Global Spine Osteoarthritis Pain Drug Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Spine Osteoarthritis Pain Drug Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Spine Osteoarthritis Pain Drug Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Spine Osteoarthritis Pain Drug Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Spine Osteoarthritis Pain Drug Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Spine Osteoarthritis Pain Drug
Table 13. Global Spine Osteoarthritis Pain Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spine Osteoarthritis Pain Drug as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Spine Osteoarthritis Pain Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Spine Osteoarthritis Pain Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Spine Osteoarthritis Pain Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Spine Osteoarthritis Pain Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Spine Osteoarthritis Pain Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Spine Osteoarthritis Pain Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Spine Osteoarthritis Pain Drug Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Spine Osteoarthritis Pain Drug Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Spine Osteoarthritis Pain Drug Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Spine Osteoarthritis Pain Drug Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Spine Osteoarthritis Pain Drug Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Spine Osteoarthritis Pain Drug Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Spine Osteoarthritis Pain Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Spine Osteoarthritis Pain Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Spine Osteoarthritis Pain Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Spine Osteoarthritis Pain Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Spine Osteoarthritis Pain Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Spine Osteoarthritis Pain Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Spine Osteoarthritis Pain Drug Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Spine Osteoarthritis Pain Drug Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Spine Osteoarthritis Pain Drug Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Spine Osteoarthritis Pain Drug Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Spine Osteoarthritis Pain Drug Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Spine Osteoarthritis Pain Drug Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Spine Osteoarthritis Pain Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Spine Osteoarthritis Pain Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Spine Osteoarthritis Pain Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Spine Osteoarthritis Pain Drug Sales Value by Region (2019-2024) & (%)
Table 44. Global Spine Osteoarthritis Pain Drug Sales Value by Region (2025-2030) & (%)
Table 45. Global Spine Osteoarthritis Pain Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Spine Osteoarthritis Pain Drug Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Spine Osteoarthritis Pain Drug Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Spine Osteoarthritis Pain Drug Sales Volume by Region (2019-2024) & (%)
Table 49. Global Spine Osteoarthritis Pain Drug Sales Volume by Region (2025-2030) & (%)
Table 50. Global Spine Osteoarthritis Pain Drug Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Spine Osteoarthritis Pain Drug Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Spine Osteoarthritis Pain Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Spine Osteoarthritis Pain Drug Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Spine Osteoarthritis Pain Drug Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Spine Osteoarthritis Pain Drug Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Spine Osteoarthritis Pain Drug Sales Volume, (2025-2030) & (K Units)
Table 57. Pfizer Company Information
Table 58. Pfizer Introduction and Business Overview
Table 59. Pfizer Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Pfizer Spine Osteoarthritis Pain Drug Product Offerings
Table 61. Pfizer Recent Development
Table 62. Johnson and Johnson Company Information
Table 63. Johnson and Johnson Introduction and Business Overview
Table 64. Johnson and Johnson Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Johnson and Johnson Spine Osteoarthritis Pain Drug Product Offerings
Table 66. Johnson and Johnson Recent Development
Table 67. GlaxoSmithKline Company Information
Table 68. GlaxoSmithKline Introduction and Business Overview
Table 69. GlaxoSmithKline Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. GlaxoSmithKline Spine Osteoarthritis Pain Drug Product Offerings
Table 71. GlaxoSmithKline Recent Development
Table 72. Bayer Company Information
Table 73. Bayer Introduction and Business Overview
Table 74. Bayer Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Bayer Spine Osteoarthritis Pain Drug Product Offerings
Table 76. Bayer Recent Development
Table 77. Eli Lilly Company Information
Table 78. Eli Lilly Introduction and Business Overview
Table 79. Eli Lilly Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Eli Lilly Spine Osteoarthritis Pain Drug Product Offerings
Table 81. Eli Lilly Recent Development
Table 82. Novartis Company Information
Table 83. Novartis Introduction and Business Overview
Table 84. Novartis Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Novartis Spine Osteoarthritis Pain Drug Product Offerings
Table 86. Novartis Recent Development
Table 87. Sanofi Company Information
Table 88. Sanofi Introduction and Business Overview
Table 89. Sanofi Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Sanofi Spine Osteoarthritis Pain Drug Product Offerings
Table 91. Sanofi Recent Development
Table 92. Horizon Pharma Company Information
Table 93. Horizon Pharma Introduction and Business Overview
Table 94. Horizon Pharma Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Horizon Pharma Spine Osteoarthritis Pain Drug Product Offerings
Table 96. Horizon Pharma Recent Development
Table 97. Abbott Company Information
Table 98. Abbott Introduction and Business Overview
Table 99. Abbott Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Abbott Spine Osteoarthritis Pain Drug Product Offerings
Table 101. Abbott Recent Development
Table 102. Mylan Company Information
Table 103. Mylan Introduction and Business Overview
Table 104. Mylan Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Mylan Spine Osteoarthritis Pain Drug Product Offerings
Table 106. Mylan Recent Development
Table 107. Daiichi Sankyo Company Information
Table 108. Daiichi Sankyo Introduction and Business Overview
Table 109. Daiichi Sankyo Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Daiichi Sankyo Spine Osteoarthritis Pain Drug Product Offerings
Table 111. Daiichi Sankyo Recent Development
Table 112. TEVA Company Information
Table 113. TEVA Introduction and Business Overview
Table 114. TEVA Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. TEVA Spine Osteoarthritis Pain Drug Product Offerings
Table 116. TEVA Recent Development
Table 117. Almatica Pharma Company Information
Table 118. Almatica Pharma Introduction and Business Overview
Table 119. Almatica Pharma Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Almatica Pharma Spine Osteoarthritis Pain Drug Product Offerings
Table 121. Almatica Pharma Recent Development
Table 122. Astellas Pharma Company Information
Table 123. Astellas Pharma Introduction and Business Overview
Table 124. Astellas Pharma Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Astellas Pharma Spine Osteoarthritis Pain Drug Product Offerings
Table 126. Astellas Pharma Recent Development
Table 127. Tide Pharmaceutical Company Information
Table 128. Tide Pharmaceutical Introduction and Business Overview
Table 129. Tide Pharmaceutical Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Tide Pharmaceutical Spine Osteoarthritis Pain Drug Product Offerings
Table 131. Tide Pharmaceutical Recent Development
Table 132. Iroko Pharmaceuticals Company Information
Table 133. Iroko Pharmaceuticals Introduction and Business Overview
Table 134. Iroko Pharmaceuticals Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Iroko Pharmaceuticals Spine Osteoarthritis Pain Drug Product Offerings
Table 136. Iroko Pharmaceuticals Recent Development
Table 137. Hengrui Pharmaceutical Company Information
Table 138. Hengrui Pharmaceutical Introduction and Business Overview
Table 139. Hengrui Pharmaceutical Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. Hengrui Pharmaceutical Spine Osteoarthritis Pain Drug Product Offerings
Table 141. Hengrui Pharmaceutical Recent Development
Table 142. Abiogen Pharma Company Information
Table 143. Abiogen Pharma Introduction and Business Overview
Table 144. Abiogen Pharma Spine Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. Abiogen Pharma Spine Osteoarthritis Pain Drug Product Offerings
Table 146. Abiogen Pharma Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Spine Osteoarthritis Pain Drug Downstream Customers
Table 150. Spine Osteoarthritis Pain Drug Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Spine Osteoarthritis Pain Drug Product Picture
Figure 2. Global Spine Osteoarthritis Pain Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Spine Osteoarthritis Pain Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Spine Osteoarthritis Pain Drug Sales Volume (2019-2030) & (K Units)
Figure 5. Global Spine Osteoarthritis Pain Drug Sales Price (2019-2030) & (USD/Unit)
Figure 6. Spine Osteoarthritis Pain Drug Report Years Considered
Figure 7. Global Spine Osteoarthritis Pain Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Spine Osteoarthritis Pain Drug Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Spine Osteoarthritis Pain Drug Revenue in 2023
Figure 10. Spine Osteoarthritis Pain Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Oral Picture
Figure 12. Injection Picture
Figure 13. External Picture
Figure 14. Global Spine Osteoarthritis Pain Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Spine Osteoarthritis Pain Drug Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Spine Osteoarthritis Pain Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Spine Osteoarthritis Pain Drug Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Spine Osteoarthritis Pain Drug Price by Type (2019-2030) & (USD/Unit)
Figure 19. Product Picture of Medical Care
Figure 20. Product Picture of Personal Care
Figure 21. Global Spine Osteoarthritis Pain Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Spine Osteoarthritis Pain Drug Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Spine Osteoarthritis Pain Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Spine Osteoarthritis Pain Drug Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Spine Osteoarthritis Pain Drug Price by Application (2019-2030) & (USD/Unit)
Figure 26. North America Spine Osteoarthritis Pain Drug Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Spine Osteoarthritis Pain Drug Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Spine Osteoarthritis Pain Drug Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Spine Osteoarthritis Pain Drug Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Spine Osteoarthritis Pain Drug Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Spine Osteoarthritis Pain Drug Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Spine Osteoarthritis Pain Drug Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Spine Osteoarthritis Pain Drug Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Spine Osteoarthritis Pain Drug Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Spine Osteoarthritis Pain Drug Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Spine Osteoarthritis Pain Drug Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Spine Osteoarthritis Pain Drug Sales Volume (%), (2019-2030)
Figure 38. United States Spine Osteoarthritis Pain Drug Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Spine Osteoarthritis Pain Drug Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Spine Osteoarthritis Pain Drug Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Spine Osteoarthritis Pain Drug Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Spine Osteoarthritis Pain Drug Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Spine Osteoarthritis Pain Drug Sales Value by Application (%), 2023 VS 2030
Figure 44. China Spine Osteoarthritis Pain Drug Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Spine Osteoarthritis Pain Drug Sales Value by Type (%), 2023 VS 2030
Figure 46. China Spine Osteoarthritis Pain Drug Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Spine Osteoarthritis Pain Drug Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Spine Osteoarthritis Pain Drug Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Spine Osteoarthritis Pain Drug Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Spine Osteoarthritis Pain Drug Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Spine Osteoarthritis Pain Drug Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Spine Osteoarthritis Pain Drug Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Spine Osteoarthritis Pain Drug Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Spine Osteoarthritis Pain Drug Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Spine Osteoarthritis Pain Drug Sales Value by Application (%), 2023 VS 2030
Figure 56. India Spine Osteoarthritis Pain Drug Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Spine Osteoarthritis Pain Drug Sales Value by Type (%), 2023 VS 2030
Figure 58. India Spine Osteoarthritis Pain Drug Sales Value by Application (%), 2023 VS 2030
Figure 59. Spine Osteoarthritis Pain Drug Industrial Chain
Figure 60. Spine Osteoarthritis Pain Drug Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
